Follow-up bone scintigraphy and rhenium application during therapy of a prostate cancer

被引：0
|
作者：
Ostwald, E
Sabri, O
Cremerius, U
Jakse, G
Büll, U
机构：
[1] Rhein Westfal TH Aachen, Klin Nukl Med, D-52057 Aachen, Germany
[2] Rhein Westfal TH Aachen, Urol Klin, D-52057 Aachen, Germany
来源：
NUKLEARMEDIZIN | 1999年 / 38卷 / 07期
关键词：
pain therapy; Rhenium-186-etidronat; osseous metastases; super bone scan;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 78-year-old patient with prostate cancer and osseous metastases had a pain symptomatic. in the Urology he was treated with antiandrogenes. The outcome of the bone scintigraphy showed a super bone scan with normalization after antiandrogene-therapy which seemed to be a sign of remission, before he showed a progressive form with multiple osseous metastases. Pain could not be treated with non steroidal antiphlogistics and opiates, so the indication for treatment with Rhenium-186-HEDP was given in this case.
引用
收藏
页码：302 / 305
页数：4
相关论文
共 50 条
  • [41] Significance of prostate specific antigen in the follow-up of patients with prostate cancer
    Hertle, L
    UROLOGE-AUSGABE A, 1998, 37 (02): : 170 - 171
  • [42] Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer
    L. M. Haslinghuis
    E. P. Krenning
    W. W. de Herder
    A. E. M. Reijs
    D. J. Kwekkeboom
    Journal of Endocrinological Investigation, 2001, 24 : 415 - 422
  • [43] PRETREATMENT PROSTATE-SPECIFIC ANTIGEN LEVELS IN NEWLY-DIAGNOSED PROSTATE-CANCER WITHOUT BONE METASTASES DO NOT PREDICT OCCURRENCE OF METASTASES ON FOLLOW-UP BONE-SCINTIGRAPHY
    JACOBSON, AF
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P225 - P226
  • [44] Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer
    Haslinghuis, LM
    Krenning, EP
    de Herder, WW
    Reijs, AEM
    Kwekkeboom, DJ
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (06) : 415 - 422
  • [45] Rising prostate specific antigen (PSA) during follow-up of prostate cancer patients -: what to do?
    Schröder, FH
    EJC SUPPLEMENTS, 2005, 3 (03): : 309 - 315
  • [46] Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis
    Hatoum, Hind T.
    Lin, Swu-Jane
    Guo, Amy
    Lipton, Allan
    Smith, Matthew R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 55 - 62
  • [47] PROSTATIC SPECIFIC ANTIGEN (PSA) AND BONE SCANNING IN FOLLOW-UP OF PROSTATE-CANCER PATIENTS S/P DEFINITIVE THERAPY
    GILVYDIS, RP
    FREITAS, JE
    FERRY, JD
    BLAKE, DC
    GONZALEZ, JA
    JOURNAL OF NUCLEAR MEDICINE, 1989, 30 (04) : AB9 - AB9
  • [48] Prostate Cancer Patients' Perceptions Regarding the Relevance of a Digital Rectal Examination During Their Follow-Up After Radiation Therapy
    Klein, Clement
    Bosc, Ninon
    Marty, Sylvie
    Calen, Laura
    Debard, Candice
    Robert, Gregoire
    Haaser, Thibaud
    CANCER MEDICINE, 2025, 14 (01):
  • [49] Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study
    A K Morgans
    K-H Fan
    T Koyama
    P C Albertsen
    M Goodman
    A S Hamilton
    R M Hoffman
    J L Stanford
    A M Stroup
    D F Penson
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 338 - 342
  • [50] Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study
    Morgans, A. K.
    Fan, K-H
    Koyama, T.
    Albertsen, P. C.
    Goodman, M.
    Hamiltons, A. S.
    Hoffman, R. M.
    Stanford, J. L.
    Stroup, A. M.
    Penson, D. F.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (04) : 338 - 342
12345